Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
US8304404B2 · kind B2 · utility
4Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 5, 2012 |
| Grant date | Nov 6, 2012 |
| Priority date | — |
| Expiry date | Apr 5, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An aspirin-theanine cocrystal composition including a quantity of acetylsalicylic acid and a quantity of a theanine enantiomer combined with the quantity of acetylsalicylic acid in a mixture. The theanine enantiomer may be L-theanine, D-theanine, or DL-theanine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.